baber/WOPTO huggingface dataset:
Patent CZ-290413-B6 (CZ)
Title: Device for driving insulating boards into masonry
Inventor: HABOCK HERWIG DIPL ING
IPC: B25D17/00
Filed: 1995-11-23
Abstract: The present invention relates to a device for driving insulating boards (4) into masonry (10) having a pneumatically, hydraulically or electrically driven driving hammer (1). Driving piston (2) of the hammer (1) acts via a clamping jaw (3) with a shaft (7) following up with the driving piston (2) and a front part (8) on the face of a single insulating board (4). The clamping jaw (3) front part (8) is provided with a slot (9), in which the face of the corresponding profiled insulating board (4) can be inserted through at least a portion of its width. A driving tool (14) consisting of a driving head (15) and a thin plate-like extension part (16) being provided at its free end with a shallow channel (17) for putting onto the insulating board face (4) and being thinner that the mortar joint (12) in which the insulating board (4) is driven, is put on the clamping jaw (3) front part (8).
Patent CZ-285437-B6 (CZ)
Title: Machine for removing old track and laying new track
Inventor: THEURER JOSEF ING
IPC: E01B27/00
Filed: 1996-10-29
Abstract: The railway track restoration machine includes a levelling device (35). It has two boundary shields (44) extending in the longitudinal direction of the machine and spaced apart in the transverse direction. The threshold transfer device (17) is positioned between the two boundary shields. The two boundary shields are joined to the levelling shield (36) by their front ends (45) as seen in the working direction and an exact levelling of the track may be performed.
Patent CZ-297375-B6 (CZ)
Title: Arrangement for reporting position of motor drives
Inventor: DOHNAL DIETER
IPC: H01H9/00
Filed: 1998-01-09
Abstract: In the present invention, there is disclosed an arrangement for reporting position of motor drives of step switches, change-over switches and coils with submerged cores comprising two separate structural groups, arrangement of reporting contacts (11) and a spatially separated position reporting module (6, 7), wherein the structural groups are electrically connected to each another to transfer information obtained in the arrangement of the reporting contacts (11) to said position reporting module (6, 7). The arrangement of the reporting contacts (11) comprises fixed reporting contacts (11) that are assigned to various working positions of a step switch, a change-over switch and a coil with submerged core and with the aid of a rotary electrically conducting contact bridge (23) they can be, directly or through the mediation of an incorporated microswitch (3), connected to a load terminal. The module (6, 7) is provided with means for processing or evaluation of information transferred from the reporting contact (11) arrangement.
Patent CZ-295910-B6 (CZ)
Title: Method of determining actual temperature of real bodies
Inventor: LINGART JURIJ K
IPC: G01J5/00
Filed: 1999-12-02
Abstract: Actual temperature of real bodies is determined by measuring spectral intensity and wavelength of calorific radiation using a non-selective receiver. Measured are wavelengths ({lambda}i1, and {lambda}i2) of calorific radiation  corresponding to inflex points on a curve representing characteristic of spectral intensity of radiation in dependence on the wavelength of this radiation Ii{lambda}T = f({lambda}, T) or to the magnitude of a wavelength corresponding to one of the inflex points ({lambda}i1,2) and {lambda}imax, corresponding to maximum of the function Ii{lambda}T = f({lambda}, T). Absolute actual temperature T of a real body is then determined from the corresponding relationship in dependence on the wavelengths {lambda}i1, {lambda}i2 and {lambda}imax.
Patent SK-283265-B6 (SK)
Title: Pharmaceutical composition for oral administration of an active substance
Inventor: ABRAMOVICI BERNARD
IPC: A61K9/16
Filed: 1998-03-27
Abstract: The invention concerns pharmaceutical compositions for oral administration containing 0.5 % to 20 % of N-piperidino-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methylpyrazole-3-carboxamide in microcrystalline form and pharmaceutical vehicles. The compositions are formulated by wet granulation.
Patent SK-278161-B6 (SK)
Title: Connection of hybrid encoder
Inventor: SURIANSKY JOZEF
IPC: H03M1/12
Filed: 1990-03-19
Abstract: Output (U1) of transformation signals of M-transformer (1) with input grip (U_in) is at the same time the input of block (2) of modul-pulse code modulation, which output (U_out) is at the same time the output of whole connection of hybrid encoder.
Patent SK-281824-B6 (SK)
Title: Composition for call-note of bark-beetles
Inventor: VARKONDA STEFAN
IPC: A01N43/08
Filed: 1996-12-19
Abstract: The agent for attracting bark beetles is designated especially to monitor occurrence and mass capturing of Pityogenes chalcographus or, as the case may be, simultaneously with Ips typographus, suitable especially for traps and pheromone dispensers. As the active component it contains a mixture of decadienoic acid derivatives of general formula (I), wherein R means methyl or methoxy group and at least one furyl derivative of general formula (II) where R<1> means H or -COCH3 group in the medium of a suitable solvent. The mixture of the above derivatives shows a synergetic effect.
Patent SK-278298-B6 (SK)
Title: Veterinary composition for treatment of digestion disorders of ruminants
Inventor: BOUDA JAN
IPC: A61K31/19
Filed: 1991-07-18
Abstract: The preparation contains of sodium propionate 50,0 up to 120,0 g, beer yeast 35,0 g up to 90,0 g in a spray form, tri-sodium citrate 1,0 up to 6,0 g, citric acid 1,5 up to 3,5 g, calcium hydrogen phosphate 18,0 up to 42,0 g, sodium chloride 5,0 up to 12,0 g, cobalt (II) sulphate 0,01 up to 0,1 g, manganese (II) sulphate 0,05 up to 0,2, copper (II) sulphate 0,05 up to 0,3 g, iron (II) sulphate 0,05 up to 0,3 g, zinc sulphate 0,005 up to 0,2 g.
Patent SK-286388-B6 (SK)
Title: Crystalline polymorph of ritonavir and method for the preparation thereof
Inventor: BAUER JOHN F
IPC: A61K31/00
Filed: 1999-07-19
Abstract: Described is a crystalline polymorph of ritonavir and methods for its use and preparation.
Patent CZ-299605-B6 (CZ)
Title: Device for bridging over expansion joints
Inventor: GALLAI GUSTAV
IPC: E01D19/08
Filed: 2000-02-29
Abstract: The present invention relates to a device for bridging over expansion joints in a roadway (3), bridges (6) and the like having at least two mirror-like disposed plates (7) provided with fingers (9) being offset by a value of the finger (9) width transversely to the finger (9) longitudinal direction and having cavities (10) in which bridging components (13) are arranged that extend from the base (14) of the cavity between the fingers (9) in the direction of their length over the finger point (15). The invention is characterized in that said bridging components (13) are formed by springing leaves (17) disposed between the fingers (9) and exceeding thereof. These springing leaves (17) bear under elastic prestress on guide surfaces (30) performed on bottom sides (29) of opposite fingers (9) and extend transversely to upper side (28) of the fingers (9).
Patent CZ-298675-B6 (CZ)
Title: Pharmaceutical composition containing clodronate and silicified microcrystalline cellulose
Inventor: LEHTOLA VELI-MATTI
IPC: A61P19/10
Filed: 1998-09-18
Abstract: In the present invention, there is disclosed a pharmaceutical composition for peroral administration, especially in the form of a tablet containing as an active component a pharmacologically acceptable salt of dichloromethylene bisphosphonic acid, i.e. clodronate, in particular disodium clodronate, and silicified microcrystalline cellulose as a carrier.
Patent CZ-298500-B6 (CZ)
Title: Creep-resisting chrome steel
Inventor: POLACH JAROMIR
IPC: C22C38/44
Filed: 2006-04-21
Abstract: In the present invention, there is disclosed a creep-resisting chrome steel intended for manufacture of products used in operating temperatures ranging from 470 degC to 650 degC containing: O.08 to O.12 percent by weight of carbon C, O.20 to O.50 percent by weight of silicon Si O.30 to O.60 percent by weight of manganese Mn, at the most O.02 percent by weight of phosphorus P, at the most O.01 percent by weight of sulfur S, 8.0 to 9.5 percent by weight of chromium Cr, O.8 to 1 percent by weight of molybdenum Mo, up to O.30 percent by weight of nickel Ni, O.06 to O.10 percent by weight of niobium Nb, O.18 to O.25 percent by weight of vanadium V, up to O.020 percent by weight of aluminium Al, up to O.005 percent by weight of titanium Ti, up to O.005 percent by weight of tungsten W, O.03 to O.1 percent by weight of nitrogen N, and the balance being iron Fe and unavoidable manufacturing impurities wherein the total content of nitrogen NiC is given by the following relations: NiC = NiVaz + NiVN is less than or equal to O.1 percent by weight, NiVaz = O.52 x al weight percent + O.29 x Ti weight prevent + O.075 x Nb weight percent, NiVN = at least O.03 percent by weight, wherein NiC is residual amount of nitrogen N, NiVaz is bonded nitrogen N, NiVN is free nitrogen N.
Patent CZ-303114-B6 (CZ)
Title: Hypothermia application device
Inventor: NOGA ZDENEK
IPC: A61B18/02
Filed: 2010-06-28
Abstract: The invented hypothermia application device using a Peltier cell when cooling down a live tissue is composed of a load-bearing structure (1) carrying at least one cooling unit (5) or at least one heat-conducting unit (12) wherein each cooling unit (5) or heat-conducting unit (12) is attached to a Peltier cell (8) being connected by its cold side with a contact element (7). Said contact element (7) is isolated, except the point of contact with the Peltier cell (8) cold side, from the environment by insulation (6) to prevent condensation of atmospheric humidity. Each cooling unit (5) or heat-conducting unit (12) being formed by a heat-conducting material is connected to the load-bearing structure (1) by a connecting element (4). Individual parts of the load-bearing structure (1) along with the cooling units (5) or heat-conducting units (12) are interconnected by a clamping device (2) for securing the contact of the contact element (7) with the live tissue. The load-bearing structure (1) being provided with holes enabling introduction of medicinal instruments and devices can be fixedly attached to a bed, and the hot side of the Peltier cell (8) is cooled.
Patent CZ-309506-B6 (CZ)
Title: Method of treating ore rock to obtain activated lithium mica concentrate
Inventor: PTICEN FRANTIŠEK
IPC: C01D15/08
Filed: 2019-05-20
Abstract: The method of processing ore rock to obtain activated lithium mica concentrate, especially of the cinvaldite, polylithionite, lepidolite, spodumene type, consists of the primary lithium Li-bearing rock or secondary lithium feedstock from tin-tungsten tailings or lithium mica concentrate is subjected to low-temperature activation of 100 to 500 °C for 1 to 30 minutes in an air-sorted dryer to remove fluorine, and its compounds and the simultaneous classification according to the specific gravity of minerals, when the removed light portion of the rock up to a specific weight of 4 g/cm3 containing mica mineral is further hot subjected to dry magnetic separation in a variable 0.35 to 1 T strong magnetic field with a to accumulate lithium Li, rubidium Rb, rare earth elements and minerals in the magnetic portion, this magnetic portion is then mechanically activated by grinding in a high-speed mill or mechanical-chemical activation by grinding in a high-speed mill with the addition of an acid selected from HF, HCl, H2SO4 or with the addition of an additive selected from NaF, CaCl2, Na2CO3, Na2SiO3, Ca(OH)2 for delaminating and increasing the specific surface area of the lithium mica concentrate particles.
Patent CZ-309081-B6 (CZ)
Title: 1-Aryloxy-3- (4- (2-hydroxyethyl) piperazin-1-yl) propan-2-oly, preparation process and use
Inventor: FILIPOVÁ ALŽBĚTA
IPC: C07D295/092
Filed: 2019-11-21
Abstract: The invention relates to 1-aryloxy-3- (4- (2-hydroxyethyl) piperazin-1-yl) propan-2-ol of formula I, where R is selected from the group consisting of phenyl substituted with 1, 2 or 3 substituents independently selected from the group consisting of methoxy and nitro; and their pharmaceutically acceptable salts with alkali metals, ammonia or amines, or their addition salts with pharmaceutically acceptable acids. These substances are suitable for use as radioprotectants based on apoptosis inhibitors.
Patent SK-287955-B6 (SK)
Title: Washer for manual washing and rinsing of beverage glass, especially beer glass
Inventor: DUBAK VLADIMIR
IPC: A47L15/14
Filed: 2007-10-24
Abstract: A washer for hand washing and rinsing of drinking glasses, especially beer glasses and glass with the ear, consists of a dishwasher (2) with mechanical brushes profitably with effective chemical cleaning agents and rinsing unit (3) with rinsing thorn (8) and side-washing (9). The washer (1) is equipped with a cold water entering to the dishwasher (2) and rinsing unit (3). Dishwasher (2) and rinsing unit (3) each have their own separate direct entry (12, 13), cold water or warm water with temperatures ranging from 25 to 50 ° C, preferably 35 to 40 ° C. Each of these separate entrance (12, 13) is directly connected to its own separate output (22, 13) for cold or hot water.
Patent CZ-300684-B6 (CZ)
Title: Process for preparing alkyl mercaptomethyl ergoline derivatives
Inventor: MANGIA ALBERTO
IPC: A61K31/48
Filed: 1999-12-31
Abstract: The present invention relates to a process for preparing alkyl mercaptomethyl ergoline derivatives of the general formula VI, which are active compounds when treating Parkinson's disease, wherein in the general formula Ri4 may be, independently, a linear, branched or cyclic, saturated or unsaturated alkyl radical containing 1 to 8 carbon atoms, such as methyl, ethyl, propyl, butyl, isobutyl, tert-butyl, pentyl, cyclopentyl, hexyl, cyclohexyl and octyl. The invention also relates to synthesis process of those compounds, said process using as starting material compounds of the general formula I wherein Ri1 represents a linear, branched or cyclic, saturated or unsaturated alkyl residue having 1 to 8 carbon atoms.
Patent CZ-299931-B6 (CZ)
Title: Composition for treating resistance to antihypertensives and the like states and use thereof
Inventor: ZISAPEL NAVA
IPC: A61P25/00
Filed: 2000-01-05
Abstract: The present invention relates to a pharmaceutical formulation, including both melatonin and at least one antihypertensive compound, as well as a method, for treating a patient who is resistant to antihypertensives in absence of melatonin, a method for lowering nocturnal blood pressure in patients who have an abnormal rhythm in blood pressure in the absence or presence of antihypertensives, and a method for imparting in a patient at least one effect selected from improvement in mood and daytime vigilance, postponement of the peak level of cortisol in the patient and potential prophylactic protection against the detrimental effects of ischemia on the heart, wherein melatonin is administered in an effective amount and manner.
Patent AT-517899-B8 (AT)
Title: PVC-freie Gefäßverschlüsse für Anwendungen in der Kälte
Inventor: DANY MÄNGEL
IPC: C09K3/10
Filed: 2012-07-12
Granted: 2017-11-15
Abstract: Die Anmeldung betrifft einen Gefäßverschluss aus Metall oder Kunststoff für ein Gefäß zur Aufnahme von Nahrungsmitteln oder Getränken unter Vakuum und bei Abfüllung und/oder Lagerung bei Raumtemperatur und darunter, mit einer Dichtungseinlage aus einem Dichtungsmaterial, welches wenigstens ein Polymer (mit Ausnahme von halogenhaltigen Polymeren, z.B. PVC) im Gemisch mit weiteren Substanzen umfasst, dadurch gekennzeichnet, dass das Dichtungsmaterial bei 20°C eine Shore A-Härte von maximal 90 und einem Druckverformungsrest (DVR) von maximal 40%. und bei 4°C eine Shore A-Härte von maximal 100 und einen DVR von maximal 50% aufweist.
Patent EP-1067193-B8 (EP)
Inventor: KREUTZER CAROLINE
IPC: C07K14/34
Filed: 2000-07-06
Granted: 2006-02-01
Abstract: New L-lysine producing coryneform bacteria (A) contain amplified pyc (pyruvate carboxylase) and dapA (dihydrodipicolinate) genes, where the promoter of the dapA gene contains the mutation MC20 or MA16 (as shown in respective sequences of 79 or 80 bases given in the specification as SEQ-ID-NO: 5 and SEQ-ID-NO: 6). (A) optionally also contains amplified lycC, lysE and/or dapB gene(s). An independent claim is included for the preparation of L-lysine by fermentation of coryneform bacteria having an amplified pyc gene, where the bacteria additionally contain the amplified dapA gene as specified for (A).
Patent EP-1572257-B8 (EP)
Title: Matiere osseuse de substitution
Inventor: RICHART OLIVIER
IPC: A61L27/10
Filed: 2003-12-16
Granted: 2006-11-02
Abstract: La présente invention concerne une matière osseuse de substitution. Pour produire cette matière osseuse de substitution granulaire, on produit une céramique synthétique macroporeuse en emballant des particules d'un composé organique dans un récipient, en soumettant ces particules à un processus de transformation de façon à obtenir une structure monobloc, en imprégnant cette structure monobloc par le remplissage des espaces de cette structure avec une suspension de phosphate de calcium, en retirant le liquide de cette suspension présente sur la structure monobloc, en retirant la structure monobloc de façon à former la matière céramique avec des macropores en interconnexion et en frittant cette matière céramique de façon à obtenir une céramique synthétique macroporeuse.
Patent BR-PI0407176-B8 (BR)
Inventor: BENGT JEPPSSON
IPC: C12R1/01
Filed: 2004-01-27
Abstract: Strains of Bifidobacterium having the ability to survive in the intestinal tract and to produce glutamine in vivo, is new. Independent claims are included for the following: (1) one or more of (I) belonging to the species Bifidobacterium infantis for use in therapy; (2) a composition (II) comprising one or more of (I), in combination with a carrier; and (3) use of one or more of (I), for the preparation of a medicament for treatment of intensive care patients with multiple organ dysfunction and intestinal failure, for prophylaxis in chemotherapy patients and patients with inflammatory diseases, or for postoperative administration after major surgery. ACTIVITY : Gastrointestinal-Gen; Hepatoprotective; Antiinflammatory. MECHANISM OF ACTION : Producer of glutamine and arginine in vivo. Effects of Bifidobacterium strains on dextran sodium sulfate (DDS) induced colitis in rat was tested. Sprague dawley rates were administered orally with different strains of Bifidobacterium for 7 days prior to the induction of colitis (day 0) and were continuously administered for 7 days in combination with DDS (5% w/v dissolved in water). The degree of colitis were determined daily with disease activity index (DAI). Sampling was performed on day 14 and bacterial translocation and quantity in the intestine was determined. DAI was significantly lower in the group receiving B.infantis CURE 19 compared to the groups receiving Lactobacillus paracasei 8700:2 and L.gasseri LG1. After 6 and 7 days, orally administered bacterial strains were able to exercise positive effects by decreasing translocation on experimental colitis in rats. CURE 19 was more effective in counteracting the colitis than the others.
Patent BR-PI0511489-B8 (BR)
Title: método de avaliação do risco relativo de desenvolver aterosclerose em pacientes
Inventor: HANDBERG AASE
IPC: G01N33/50
Filed: 2005-05-26
Abstract: método de avaliação do risco relativo de desenvolver aterosclerose em pacientes a presente invenção se refere a um método para determinar a quantidade de proteína de cd36 circulante ou uma fração desta que está presente em plasma livre de célula, preferivelmente em uma fração de plasma de alto peso molecular, tal como uma fração de lipoproteina selecionada a partir de lipoproteina de baixa densidade, lipoproteína de densidade intermediária, e lipoproteína de muito baixa densidade empregando um método imunológico que compreende as etapas de (i) fornecer uma amostra de plasma a ser investigada, (i - i) fornecer um anticorpo anti-cd36, (iii) expor a amostra a ser investigada ao anticorpo, e (iv) detectar e quantificar a quantidade de cd36 que liga-se ao anticorpo.
Patent BR-PI0516243-B8 (BR)
Title: uso de um precursor de esteróide sexual selecionado do grupo que consiste em dehidroepiandrosterona, sulfato de dehidroepiandrosterona, androst-5-eno-3b,17b-diol e 4-androsten-3,17-diona, uso do referido precursor em 5 associação com um modulador de receptor de estrogênio seletivo para proteção uterina e da glândula mamária contra câncer, composição farmacêutica e kit
Inventor: FERNAND LABRIE
IPC: A61K31/566
Filed: 2005-10-20
Abstract: precursores de esteróide sexual isolados ou em combinação com um modulador de receptor estrogênio seletivo e/ou com estrogênios e/ou inibidor de fosfodiesterase de cgmp tipo 5 para a prevenção e tratamento de secura vaginal e disfunção sexual em mulheres na pós-menopausa. novos métodos para o tratamento ou redução da probabilidade de adquirir disfunção vaginal, mais particularmente secura vaginal e dispareunia, levando a disfunção sexual e baixo desejo e performance sexual, em animais de sangue quente suscetíveis incluindo humanos que envolve a administração de um precursor de esteróide sexual. a administração adicional de estrogênio ou modulador de receptor estrogênio seletivo, particularmente aqueles selecionados do grupo que consiste em raloxifeno, arzoxifeno, tamoxifeno, droloxifeno, toremifeno, iodoxifeno, gw 5638, tse-424, era-923 e lasofoxifeno, e mais particularmente compostos que têm a estrutura geral são especificamente revelados para o tratamento médico e/ou inibição do desenvolvimento de algumas das doenças acima mencionadas. composições farmacêuticas para liberação de ingrediente(s) ativo(s) e kit(s) úteis para a invenção também são revelados.
Patent BR-PI0606193-B8 (BR)
Title: artigo do vestuário descartável
Inventor: TOMOKO SUGITO
IPC: A61F5/44
Filed: 2006-01-19
Abstract: artigo do vestuário descartável. o objetivo da presente invenção é prover um artigo do vestuário descartável aperfeiçoado de modo que um par de tiras de folha conectora usada para conectar as regiões anterior e posterior de cintura entre si possam ser facilmente dobradas. as tiras das folhas conectoras usadas para conectar as regiões anterior e posterior de cintura (6, 7) do artigo (1) o qual respectivamente inclui seções proximais (51) e seções do tipo-aba (52). as seções proximais (51) são fixadas na região posterior de cintura (7) sobre sua superfície interna ao longo das zonas (50) imediatamente adjacente às bordas laterais opostas transversalmente da região posterior de cintura (7) e as seções do tipo-aba (52) estendem-se a partir das respectivas zonas (50) para o interior do artigo (1) em uma direção circunferencial. as seções do tipo-aba (52) são formadas com meios guia de dobragem (55) facilitando que as seções do tipo-aba (52) sejam dobradas de modo que estas seções do tipo-aba (52) possam estenderem-se do interior em direção ao exterior do artigo (1).
Patent BR-PI0711524-B8 (BR)
Inventor: AKIYOSHI SANADA
IPC: B60R21/231
Filed: 2007-09-27
Abstract: The knee-protecting airbag apparatus includes an airbag folded and housed in a lower area inside the column cover. The airbag pushes and opens a door section on the column cover upon deployment. When the door section is thus opened, a door of the door section blocks off an allowance gap formed between an outer circumference of the column cover subjected to position adjustment and a lower area of a peripheral region of an installation opening on a dashboard for installing the column cover by locating a rear edge region of the door to abut on a rear side of the dashboard or the lower area of the peripheral region of the installation opening on the rear side of the dashboard.